Thursday, July 1, 2010

Nerve Center Test Gets First Post-SCOTUS Application

The Legal Intelligencer reports on a recent ruling that GlaxoSmithKline is a citizen of Pennsylvania (where it has its corporate headquarters), preventing removal of a products liability case to federal court.  This marks a change from the pre-Hertz decisions where courts in circuits that did not apply the nerve center test would hold that such companies are citizens of a state in which most major manufacturing takes place.


Federal Courts, Recent Decisions | Permalink


Post a comment